[96a5a0]: / output / allTrials / identified / NCT04648462_identified.json

Download this file

228 lines (228 with data), 9.0 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
{
"info": {
"nct_id": "NCT04648462",
"official_title": "Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology",
"inclusion_criteria": "1. All brain tumors with a favorable prognosis (median survival > 10 year)\n2. Age ≥ 18 years\n3. ECOG performance status 0 - 1 / Karnofsky performance status 80 - 100\n4. No - minimal neurocognitive impairment\n5. Dosimetrical gain of protontherapy relative to photontherapy (≥5% on supratentorial brain dose or hippocampi)\n6. Informed consent\nMust have minimum age of 18 Years",
"exclusion_criteria": "1. Not eligible for chemotherapy\n2. Eligible for stereotactic radiotherapy",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. All brain tumors with a favorable prognosis (median survival > 10 year)",
"criterions": [
{
"exact_snippets": "brain tumors",
"criterion": "brain tumors",
"requirements": [
{
"requirement_type": "prognosis",
"expected_value": "favorable"
}
]
},
{
"exact_snippets": "median survival > 10 year",
"criterion": "median survival",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 10,
"unit": "year"
}
}
]
}
]
},
{
"line": "2. Age ≥ 18 years",
"criterions": [
{
"exact_snippets": "Age ≥ 18 years",
"criterion": "age",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "3. ECOG performance status 0 - 1 / Karnofsky performance status 80 - 100",
"criterions": [
{
"exact_snippets": "ECOG performance status 0 - 1",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
},
{
"exact_snippets": "Karnofsky performance status 80 - 100",
"criterion": "Karnofsky performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 80,
"unit": "N/A"
},
{
"operator": "<=",
"value": 100,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "4. No - minimal neurocognitive impairment",
"criterions": [
{
"exact_snippets": "No - minimal neurocognitive impairment",
"criterion": "neurocognitive impairment",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "minimal"
}
]
}
]
},
{
"line": "5. Dosimetrical gain of protontherapy relative to photontherapy (≥5% on supratentorial brain dose or hippocampi)",
"criterions": [
{
"exact_snippets": "Dosimetrical gain of protontherapy relative to photontherapy (≥5% on supratentorial brain dose",
"criterion": "dosimetrical gain of protontherapy relative to photontherapy on supratentorial brain dose",
"requirements": [
{
"requirement_type": "gain",
"expected_value": {
"operator": ">=",
"value": 5,
"unit": "%"
}
}
]
},
{
"exact_snippets": "Dosimetrical gain of protontherapy relative to photontherapy (≥5% on ... hippocampi",
"criterion": "dosimetrical gain of protontherapy relative to photontherapy on hippocampi",
"requirements": [
{
"requirement_type": "gain",
"expected_value": {
"operator": ">=",
"value": 5,
"unit": "%"
}
}
]
}
]
},
{
"line": "6. Informed consent",
"criterions": [
{
"exact_snippets": "Informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Not eligible for chemotherapy",
"criterions": [
{
"exact_snippets": "Not eligible for chemotherapy",
"criterion": "chemotherapy eligibility",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
}
]
},
{
"line": "2. Eligible for stereotactic radiotherapy",
"criterions": [
{
"exact_snippets": "Eligible for stereotactic radiotherapy",
"criterion": "stereotactic radiotherapy eligibility",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}